Stat
- STAT+: Former Mylan IT exec pleads guilty to insider trading on earnings, drug approvals, and merger
- STAT+: With new colon cancer study results, Mirati lays claim to best KRAS-blocking drug
- STAT+: ‘A solid black eye’: Drug pricing reform advocates scramble to reset after setback in Congress
- FDA advisory panel recommends booster doses of Covid-19 vaccine only for older and high-risk Americans
- STAT+: U.K. government launches a new system to monitor clinical trial reporting
NYT science news
- Joe Manchin Will Craft U.S. Climate Plan
- Fighting a Pandemic, While Launching Africa’s Health Revolution
- SpaceX's Inspiration4 Civilian Crew Completes 3-Day Mission
- After Egress, SpaceX Inspiration4 Astronauts to Get Health Check
- SpaceX Inspiration4 Live Updates: The Astronauts Have Splashed Down in the Atlantic Ocean.
Fierce Biotech
- Gynesonics nabs FDA clearance for updated ultrasound-powered ablation system to shrink uterine fibroids
- Hong Kong COVID tester Prenetics sets up $1.7B SPAC deal
- Pyxis Oncology names new CMO to lead development of next-gen antibody-drug conjugates
- Medtronic buys implanted infusion pump tech to develop new Type 1 diabetes therapy
- Excision's CRISPR gene editing therapy for HIV is heading into human testing after FDA clearance
Fierce Medical Devices
- Gynesonics nabs FDA clearance for updated ultrasound-powered ablation system to shrink uterine fibroids
- Hong Kong COVID tester Prenetics sets up $1.7B SPAC deal
- Medtronic buys implanted infusion pump tech to develop new Type 1 diabetes therapy
- First witnesses in Elizabeth Holmes' fraud trial say Theranos manipulated lab data, inflated revenue projections
- FDA appoints CIO, reorganizes IT, cybersecurity efforts into single digital office